Recombinant Mouse Proteinase-Activated Receptor 2 (F2rl1) is a synthetic, laboratory-produced protein corresponding to the mouse homolog of PAR2, a G-protein coupled receptor (GPCR) encoded by the F2rl1 gene. It is engineered for research purposes to study PAR2's roles in inflammation, immune regulation, pain signaling, and cellular signaling pathways. The recombinant protein is typically expressed in prokaryotic systems (e.g., E. coli) and fused with tags (e.g., His, GST) for purification and functional studies .
Domain Organization: Full-length recombinant PAR2 includes residues 39–399 (mouse) with a His tag for affinity chromatography .
Molecular Weight: ~40–42 kDa (varies based on tags and expression systems) .
Post-Translational Modifications: Includes proteolytic cleavage sites for activation by trypsin, tryptase, or synthetic peptides (e.g., SLIGRL) .
PAR2 is activated via proteolytic cleavage of its N-terminal domain, exposing a tethered ligand (SLIGKV) that binds to extracellular loop 2 (ECL2) . Key signaling pathways include:
Mitogen-Activated Protein Kinase (MAPK): Modulates cell migration and proliferation .
NF-κB/IκB Kinase (IKK): Regulates pro-inflammatory cytokines (e.g., IL-6, IL-8) .
Rho Kinase: Controls cytoskeletal rearrangement and chemotaxis .
| Pathway | Biological Outcome | Associated Proteases |
|---|---|---|
| PLC → Ca²⁺ signaling | Vasodilation, immune cell activation | Trypsin, tryptase, kallikreins |
| MAPK → Proliferation | Tumor progression, fibrosis | PAR1 transactivation |
| NF-κB → Cytokines | Inflammation, antimicrobial responses | TLR4 synergism |
ELISA Kits: Quantify F2rl1 levels in mouse serum, plasma, or tissue lysates (detection range: 0.312–20 ng/mL; sensitivity: 0.18 ng/mL) .
Western Blotting: Validate protein expression and post-translational modifications using His-tagged recombinant PAR2 .
Agonist Screening: Synthetic peptides (e.g., SLIGRL) mimic proteolytic activation to study PAR2-mediated responses in immune cells, neurons, and epithelial cells .
Colitis Models: PAR2 agonists (e.g., SLIGRL-NH₂) reduce TNBS-induced colitis by suppressing IFN-γ and IL-12 production in T lymphocytes .
Pain Signaling: Conditional knockout mice (F2rl1 flox) reveal PAR2’s role in mechanical allodynia and thermal hyperalgesia via nonpeptidergic DRG neurons .
Anti-Inflammatory Effects: PAR2 activation inhibits JNK phosphorylation and TNF-α signaling, mitigating colitis severity .
Antimicrobial Activity: Enhances phagocytosis of Gram-positive bacteria and synergizes with IFN-γ to combat viral infections .
Neuronal PAR2: Expressed in ~4% of DRG neurons, co-localizing with P2X3 and IL31RA. Activation induces mechanical allodynia via calcium-dependent pathways .
Non-Neuronal Mechanisms: Endogenous proteases (e.g., neutrophil elastase) mediate thermal hyperalgesia independently of neuronal PAR2 .